搜索筛选:
搜索耗时1.4658秒,为你在为你在102,285,761篇论文里面共找到 13 篇相符的论文内容
类      型:
[会议论文] 作者:Yang Liu,Dongyang Liu,Ji Jiang,Pei Hu, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Diabetes mellitus is one of the most common chronic disease in the world, CPRC 1 is a novel dipeptidylpeptidase-Ⅳ(DPP-4) inhibitor which was proposed to control hyperglycemia in patients with type 2 d...
[会议论文] 作者:Xin Zheng,Kairui Feng,Pei Hu,Ji Jiang,Jun Shi, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium 年份:2013
[会议论文] 作者:Hongyun Wang,Xia Chen,Jun Shi,Ji Jiang,Pei Hu, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Aim:Todevelop and validate a general physiologicallybased pharmacokinetic (PBPK) model for hepatic pathway in Chinese adults at various ages, and to evaluate it with midazolam (substrate of CYP3A4) as...
[会议论文] 作者:Jia Chen,Dongyang Liu,Qian Zhao,Ji Jiang,Pei Hu, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Objective:Icotinib is a potent small-molecule inhibitor of epidermal growth factor receptor (EGFR)-tyrosine kinase (TKI), which was designed for the treatment of non-small cell lung cancer (NSCLC).It...
[会议论文] 作者:Kairui Feng,Xin Zheng,Wenyuan Qi,Pei Hu,Ji Jiang, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Background: XQ (Carfree, Nanjing, China), a new chemical entity that possesses pharmacological activity on PlateletActivating Factor (PAF).XQ was approved into phase Ⅰ evaluation for treatment of isch...
[会议论文] 作者:Dongyang Liu,Hong Yang,Jiaming Qian,Ji Jiang,Pei Hu, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Esomeprazole has proved to be effective for the treatment of gastroesophogeal reflux disease (GERD) and ulcers, where intra-gastric pH value is a biomarker to indicate esomeprazole effects on these di...
[会议论文] 作者:Xin Zheng,Tao Liu,Qian Zhao,Pei Hu,Ji Jiang, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Objective:CPRC-Y is a pegylatedrecombinant human growth hormone (rhGH) developed with the aim of reducing serum clearance and thereby prolonging the exposure leading to once-weekly sc administration.T...
[会议论文] 作者:Xin Zheng,Kairui Feng,Pei Hu,Jun Shi,Ji Jiang, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Background:Concentration dependent Blood to plasma ratio (B/P) of zonisamide(ZNS) was observed in clinical trial, which requires measuring both plasma concentration and whole blood concentration for c...
[会议论文] 作者:Rui Chen,Dongyang Liu,Jun Shi,Ji Jiang,Pei Hu, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Objective:In vitro information on dextromethorphan (DXM) and the Advanced Dissolution Absorption Metabolism (ADAM) model, incorporated into PBPK simulator Simcyp(@) (v.12) were used to investigate dif...
[会议论文] 作者:Sheng Feng,Yumi Fukushima,Pei Hu,Conni Weber,Yongqing Wang,Jun Shi, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Background and Rationale: Physiologically-based pharmacokinetics (PBPK) modelling is a key component of model-based drug development and is increasingly embraced within the industry and regulatory aut...
[会议论文] 作者:Wen Zhong,Xia Chen,Qian Zhao,Ji Jiang,Tao Liu,Hong-zhong Liu,Pei Hu, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
  Background: Dermatopharmacokinetic (DPK) bioequivalence (BE) evaluation required assessments of stratum corneum (SC) drug content.The SC samples are normall...
[会议论文] 作者:Tao Liu,Ji Jiang,Xin Zheng,Qian Zhao,Xia Zhao,Yimin Cui,Pei Hu, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Aim:Rivaroxaban (Bayer Healthcare AG, Wuppertal, Germany), an oral, direct factor Xa (FXa) inhibitor for the prevention and treatment of thromboembolic disorders has been approved for nonvalvular atri...
[会议论文] 作者:Wen Zhong,Hong-Zhong Liu,Xin Zheng,Dong-Yang Liu,Jia Chen,Pei Hu,Jun Shi,Ji Jiang, 来源:第四届定量药理学与新药评价国际会议·2013(The 4th International Symposium in Qu 年份:2013
Background: The distribution of renal function and its effect on drug elimination was not well understood in Chinese population, which impeded the clinical therapeutics for Chinese patients as well as...
相关搜索: